Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the gynecological drugs market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the gynecological drugs market along with the impact they have on the demand over the estimated period. Additionally, the report includes the study of opportunities available in the gynecological drugs market on a global level.

In order to give the users of this report a comprehensive view of the gynecological drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the gynecological drugs market by segmenting the market based on therapeutics, indication, distribution channel, and region. All the segments have been analyzed based on present and future trends in the market that is estimated from 2019 to 2025. Based on therapeutics, the market is segmented into hormonal therapy and non-hormonal therapy. Based on the indication, the market is segmented into gynecology infections, gynecology cancers, endometriosis, polycystic ovary syndrome, female infertility, menopausal disorder, contraception (birth control), and others. Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the gynecological drugs market are Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer, Inc., Amgen Inc., AstraZeneca, Allergan, and Bayer AG, among others.

The report segments the global gynecological drugs market into:

Global Gynecological Drugs Market: Therapeutics Analysis

	Hormonal therapy 
	Non-Hormonal therapy 

Global Gynecological Drugs Market: Indication Type Analysis

	Gynecology Cancers
	Endometriosis
	Female Infertility
	Menopausal Disorder
	Gynecology Infections
	Polycystic Ovary Syndrome
	Contraception (Birth Control)
	Others

Global Gynecological Drugs Market: Distribution Channel Analysis

	Hospital Pharmacies
	Retail Pharmacies
	Online Pharmacies

Global Gynecological Drugs Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa